Micah Rose

503 total citations
17 papers, 356 citations indexed

About

Micah Rose is a scholar working on Economics and Econometrics, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Micah Rose has authored 17 papers receiving a total of 356 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Economics and Econometrics, 3 papers in Surgery and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Micah Rose's work include Health Systems, Economic Evaluations, Quality of Life (6 papers), Pharmaceutical Economics and Policy (3 papers) and Pharmaceutical industry and healthcare (2 papers). Micah Rose is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (6 papers), Pharmaceutical Economics and Policy (3 papers) and Pharmaceutical industry and healthcare (2 papers). Micah Rose collaborates with scholars based in United Kingdom, Belgium and Rwanda. Micah Rose's co-authors include Kian Fan Chung, Joseph C. Kidney, Patricia M. Taylor, Peter J. Barnes, Petra Harris, Keith Cooper, Jonathan Shepherd, Joanna Picot, Geoff K Frampton and Jeremy Jones and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Journal of Respiratory and Critical Care Medicine and Health Technology Assessment.

In The Last Decade

Micah Rose

14 papers receiving 331 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Micah Rose United Kingdom 8 163 151 48 40 40 17 356
Susan Robson Switzerland 7 62 0.4× 135 0.9× 25 0.5× 50 1.3× 29 0.7× 17 826
Lisa Lohr United States 5 41 0.3× 61 0.4× 48 1.0× 25 0.6× 105 2.6× 12 316
Péter Magyar Hungary 12 313 1.9× 341 2.3× 8 0.2× 8 0.2× 47 1.2× 43 556
Kimberly Ruiz United States 6 64 0.4× 36 0.2× 22 0.5× 23 0.6× 9 0.2× 15 319
Raymond Miao United States 15 55 0.3× 109 0.7× 8 0.2× 28 0.7× 14 0.3× 26 426
A. Sonia Buist United States 7 170 1.0× 203 1.3× 19 0.4× 58 1.4× 6 0.1× 9 446
Leonard Fromer United States 11 263 1.6× 187 1.2× 10 0.2× 13 0.3× 12 0.3× 26 447
Lucie‐Marie Scailteux France 12 17 0.1× 184 1.2× 15 0.3× 7 0.2× 14 0.3× 40 391
Sandrine Kerbrat France 9 25 0.2× 62 0.4× 12 0.3× 17 0.4× 75 1.9× 27 349
Muzaffer Çakmak Türkiye 13 61 0.4× 47 0.3× 19 0.4× 13 0.3× 130 3.3× 30 457

Countries citing papers authored by Micah Rose

Since Specialization
Citations

This map shows the geographic impact of Micah Rose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Micah Rose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Micah Rose more than expected).

Fields of papers citing papers by Micah Rose

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Micah Rose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Micah Rose. The network helps show where Micah Rose may publish in the future.

Co-authorship network of co-authors of Micah Rose

This figure shows the co-authorship network connecting the top 25 collaborators of Micah Rose. A scholar is included among the top collaborators of Micah Rose based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Micah Rose. Micah Rose is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
2.
Rose, Micah, et al.. (2022). From Grassroots to Systems Change: Art for Social Justice. The Journal of Arts Management Law and Society. 52(5). 308–322.
3.
Rose, Micah, Jonathan Shepherd, Petra Harris, Karen Pickett, & Joanne Lord. (2018). Etelcalcetide for Treating Secondary Hyperparathyroidism: An Evidence Review Group Evaluation of a NICE Single Technology Appraisal. PharmacoEconomics. 36(11). 1299–1308. 3 indexed citations
4.
5.
Rose, Micah, Stephen Rice, & Dawn Craig. (2017). Does Methodological Guidance Produce Consistency? A Review of Methodological Consistency in Breast Cancer Utility Value Measurement in NICE Single Technology Appraisals. PharmacoEconomics - Open. 2(2). 97–107. 3 indexed citations
6.
Cooper, Keith, Petra Harris, Micah Rose, et al.. (2017). Migalastat for treating Fabry disease. ePrints Soton (University of Southampton).
7.
Picot, Joanna, Micah Rose, Keith Cooper, et al.. (2017). Virtual chromoendoscopy for the real-time assessment of colorectal polyps in vivo: a systematic review and economic evaluation. Health Technology Assessment. 21(79). 1–308. 21 indexed citations
8.
Carroll, Christopher, Eva Kaltenthaler, Paul Tappenden, et al.. (2016). The Role and Impact of Evidence Review Group Analyses in the Nice Single Technology Assessment (STA) Process. Value in Health. 19(7). A468–A469. 1 indexed citations
9.
Kaltenthaler, Eva, Christopher Carroll, Daniel Hill‐McManus, et al.. (2016). Issues Related to the Frequency of Exploratory Analyses by Evidence Review Groups in the NICE Single Technology Appraisal Process. PharmacoEconomics - Open. 1(2). 99–108. 4 indexed citations
10.
Carroll, Christopher, Eva Kaltenthaler, Daniel Hill‐McManus, et al.. (2016). The Type and Impact of Evidence Review Group Exploratory Analyses in the NICE Single Technology Appraisal Process. Value in Health. 20(6). 785–791. 5 indexed citations
11.
Kaltenthaler, Eva, Christopher Carroll, Daniel Hill‐McManus, et al.. (2016). The use of exploratory analyses within the National Institute for Health and Care Excellence single technology appraisal process: an evaluation and qualitative analysis. Health Technology Assessment. 20(26). 1–48. 11 indexed citations
12.
Pickett, Karen, Micah Rose, Emma Loveman, et al.. (2016). Necitumumab for untreated advanced or metastatic squamous non-small-cell lung cancer. ePrints Soton (University of Southampton). 1 indexed citations
13.
Shepherd, Jonathan, Keith Cooper, Petra Harris, Joanna Picot, & Micah Rose. (2016). The clinical effectiveness and cost-effectiveness of abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis: a systematic review and economic evaluation. Health Technology Assessment. 20(34). 1–222. 43 indexed citations
14.
Frampton, Geoff K, Jeremy Jones, Micah Rose, & Liz Payne. (2016). Placental growth factor (alone or in combination with soluble fms-like tyrosine kinase 1) as an aid to the assessment of women with suspected pre-eclampsia: systematic review and economic analysis. Health Technology Assessment. 20(87). 1–160. 32 indexed citations
15.
Corbett, Mark, Morag Heirs, Micah Rose, et al.. (2015). The delivery of chemotherapy at home: an evidence synthesis. SHILAP Revista de lepidopterología. 3(14). 1–182. 14 indexed citations
16.
Wade, Ros, Micah Rose, Aileen Neilson, et al.. (2013). Ruxolitinib for the Treatment of Myelofibrosis: A NICE Single Technology Appraisal. PharmacoEconomics. 31(10). 841–852. 13 indexed citations
17.
Kidney, Joseph C., et al.. (1995). Immunomodulation by Theophylline in Asthma. Demonstration by Withdrawal of Therapy. American Journal of Respiratory and Critical Care Medicine. 151(6). 1907–1914. 192 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026